Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Internal Medicine Neurology Oncology Pediatrics Respiratory Medicine Surgery
Congress Coverage
2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting

Keynote Webinar | Spotlight on Diet and Diabetes

Watch on-demand

An expert-led symposium exploring the prevention and management of type 2 diabetes through dietary interventions. 
ADVANCED SEARCH
Log in
Top
Techniques in Coloproctology
Published in: Techniques in Coloproctology 12/2023

18-06-2023 | Enterostomy | Review

Clinical management of high-output stoma: a systematic literature review and meta-analysis

Authors: H. Lederhuber, L. H. Massey, V. E. Kantola, M. R. S. Siddiqui, A. E. Sayers, F. D. McDermott, I. R. Daniels, N. J. Smart

Published in: Techniques in Coloproctology | Issue 12/2023

Login to get access

Abstract

Purpose

High output is a common complication after stoma formation. Although the management of high output is described in the literature, there is a lack of consensus on definitions and treatment. Our aim was to review and summarise the current best evidence.

Methods

MEDLINE, Cochrane Library, BNI, CINAHL, EMBASE, EMCARE, and ClinicalTrials.gov were searched from 1 Jan 2000 to 31 Dec 2021 for relevant articles on adult patients with a high-output stoma. Patients with enteroatmospheric fistulas and case series/reports were excluded. Risk of bias was assessed using RoB2 and MINORS. The review was registered in PROSPERO (CRD42021226621).

Results

The search strategy identified 1095 articles, of which 32 studies with 768 patients met the inclusion criteria. These studies comprised 15 randomised controlled trials, 13 non-randomised prospective trials, and 4 retrospective cohort studies. Eighteen different interventions were assessed. In the meta-analysis, there was no difference in stoma output between controls and somatostatin analogues (g − 1.72, 95% CI − 4.09 to 0.65, p = 0.11, I2 = 88%, t2 = 3.09), loperamide (g − 0.34, 95% CI − 0.69 to 0.01, p = 0.05, I2 = 0%, t2 = 0) and omeprazole (g − 0.31, 95% CI  − 2.46 to 1.84, p = 0.32, I2 = 0%, t2 = 0). Thirteen randomised trials showed high concern of bias, one some concern, and one low concern. The non-randomised/retrospective trials had a median MINORS score of 12 out of 24 (range 7–17).

Conclusion

There is limited high-quality evidence favouring any specific widely used drug over the others in the management of high-output stoma. Evidence, however, is weak due to inconsistent definitions, risk of bias and poor methodology in the existing studies. We recommend the development of validated core descriptor and outcomes sets, as well as patient-reported outcome measures.
Appendix
Available only for authorised users
Literature
1.
Harris DA, Egbeare D, Jones S, Benjamin H, Woodward A, Foster ME (2005) Complications and mortality following stoma formation. Ann R Coll Surg Engl 87(6):427–431 PubMedPubMedCentralCrossRef
2.
Nightingale J (2001) Intestinal failure. London: Greenwich Medical Media
3.
Phillips SF, Giller J (1973) The contribution of the colon to electrolyte and water conservation in man. J Lab Clin Med 81(5):733–746 PubMed
4.
Debongnie JC, Phillips SF (1978) Capacity of the human colon to absorb fluid. Gastroenterology 74(4):698–703 PubMedCrossRef
5.
Nightingale J, Woodward JM, Small Bowel and Nutrition Committee of the British Society of Gastroenterology (2006) Guidelines for management of patients with a short bowel. Gut 55(Suppl 4):iv1–iv12 PubMedPubMedCentral
6.
Williams RN, Hemingway D, Miller AS (2009) Enteral Clostridium difficile, an emerging cause for high-output ileostomy. J Clin Pathol 62(10):951–953 PubMedCrossRef
7.
Hanna S, Mac II (1960) The influence of aldosterone on magnesium metabolism. Lancet 2(7146):348–350 PubMedCrossRef
8.
Hessov I, Andersson H, Isaksson B (1983) Effects of a low-fat diet on mineral absorption in small-bowel disease. Scand J Gastroenterol 18(4):551–554 PubMedCrossRef
9.
10.
Ovesen L, Chu R, Howard L (1983) The influence of dietary fat on jejunostomy output in patients with severe short bowel syndrome. Am J Clin Nutr 38(2):270–277 PubMedCrossRef
11.
Nightingale JM, Lennard-Jones JE, Gertner DJ, Wood SR, Bartram CI (1992) Colonic preservation reduces need for parenteral therapy, increases incidence of renal stones, but does not change high prevalence of gall stones in patients with a short bowel. Gut 33(11):1493–1497 PubMedPubMedCentralCrossRef
12.
13.
Higgins JPT, Thomas J, Chandler J et al (2022) Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane Collaboration
14.
Page MJ, McKenzie JE, Bossuyt PM, et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg 88:105906 PubMedCrossRef
15.
Page MJ, Moher D, Bossuyt PM, et al (2021) PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ 372:n160 PubMedPubMedCentralCrossRef
16.
17.
Sterne JAC, Savovic J, Page MJ et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898 PubMedCrossRef
18.
Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J (2003) Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg 73(9):712–716 PubMedCrossRef
19.
20.
R Core Team (2022) R: A language and environment for statistical computing. R Foundation for Statistical Computing
21.
RStudio Team (2022) RStudio: integrated development environment for R. RStudio, PBC
22.
23.
Viechtbauer W (2010) Conducting meta-analyses in R with the metafor package. J Stat Softw 36(3):1–48 CrossRef
24.
Harrer M, Cuijpers P, Furukawa T, Ebert DD (2019) Dmetar: companion R package for the guide 'Doing Meta-Analysis in R'
25.
McGuinness LA (2019) robvis: An R package and web application for visualising risk-of-bias assessments
26.
Wan X, Wang W, Liu J, Tong T (2014) Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol 14:135 PubMedPubMedCentralCrossRef
27.
Paule RC, Mandel J (1982) Consensus values and weighting factors. J Res Natl Bur Stand (1977) 87(5):377–385 PubMedCrossRef
28.
Sidik K, Jonkman JN (2002) A simple confidence interval for meta-analysis. Stat Med 21(21):3153–3159 PubMedCrossRef
29.
Knapp G, Hartung J (2003) Improved tests for a random effects meta-regression with a single covariate. Stat Med 22(17):2693–2710 PubMedCrossRef
30.
Hedges L (1981) Distribution theory for glass’s estimator of effect size and related estimators. J Educ Stat 6(2):107–128 CrossRef
31.
Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539–1558 PubMedCrossRef
32.
Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L (2008) Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry. J Clin Epidemiol 61(10):991–996 PubMedCrossRef
33.
Duval S, Tweedie R (2000) Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56(2):455–463 PubMedCrossRef
34.
35.
Sterne JA, Sutton AJ, Ioannidis JP et al (2011) Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 343:d4002 PubMedCrossRef
36.
37.
Tytgat G, Huibregtse K, Dagevos J, van den Ende A (1977) Effect of loperamide on fecal output and composition in well-established ileostomy and ileorectal anastomosis. Am J Digestive Dis 22(8):669–676 CrossRef
38.
Aly A, Barany F, Kollberg B, Monsen U, Wisen O, Johansson C (1980) Effect of an H2-receptor blocking agent on diarrhoeas after extensive small bowel resection in Crohn’s disease. Acta Med Scand 207(1–2):119–122 PubMedCrossRef
39.
King R, Norton T, Hill G (1982) A double-blind crossover study of the effect of loperamide hydrochloride and codeine phosphate on ileostomy output. Aust N Z J Surg 52(2):121–124 PubMedCrossRef
40.
Rodrigues CA, Lennard-Jones JE, Thompson DG, Farthing MJ (1989) The effects of octreotide, soy polysaccharide, codeine and loperamide on nutrient, fluid and electrolyte absorption in the short-bowel syndrome. Aliment Pharmacol Ther 3(2):159–169 PubMedCrossRef
41.
Beaugerie L, Cosnes J, Verwaerde F et al (1991) Isotonic high-sodium oral rehydration solution for increasing sodium absorption in patients with short-bowel syndrome. Am J Clin Nutr 53(3):769–772 PubMedCrossRef
42.
Kusuhara K, Kusunoki M, Okamoto T, Sakanoue Y, Utsunomiya J (1992) Reduction of the effluent volume in high-output ileostomy patients by a somatostatin analogue, SMS 201–995. Int J Colorectal Dis 7(4):202–205 PubMedCrossRef
43.
Jeppesen P, Staun M, Tjellesen L, Mortensen P (1998) Effect of intravenous ranitidine and omeprazole on intestinal absorption of water, sodium, and macronutrients in patients with intestinal resection. Gut 43(6):763–769 PubMedPubMedCentralCrossRef
44.
Heydorn S, Jeppesen PB, Mortensen PB (1999) Bile acid replacement therapy with cholylsarcosine for short-bowel syndrome. Scand J Gastroenterol 34(8):818–823 PubMedCrossRef
45.
Ecker K-W, Stallmach A, Seitz G, Gierend M, Greinwald R, Achenbach U (2003) Oral budesonide significantly improves water absorption in patients with ileostomy for crohn disease. Scand J Gastroenterol 38(3):288–293 PubMedCrossRef
46.
Clarebrough E, Guest G, Stupart D (2015) Eating marshmallows reduces ileostomy output: a randomized crossover trial. Colorectal Dis 17(12):1100–1103 PubMedCrossRef
47.
Kristensen K, Qvist N (2017) The acute effect of loperamide on ileostomy output: a randomized, double-blinded, placebo-controlled, crossover study. Basic Clin Pharmacol Toxicol 121(6):493–498 PubMedCrossRef
48.
Naimi RM, Hvistendahl M, Enevoldsen LH et al (2019) Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome: a randomised phase 2 trial. Lancet Gastroenterol Hepatol 4(5):354–363 PubMedCrossRef
49.
Mesli Y, Holterbach L, Delhorme J-B et al (2021) Is lanreotide really useful in high output stoma? Comparison between lanreotide to conventional antidiarrheal treatment alone. J Invest Surg 34(12):1312–1316 PubMedCrossRef
50.
Culkin A, Gabe SM, Nightingale JMD (2022) A new palatable oral rehydration solution: a randomised controlled cross-over study in patients with a high output stoma. J Hum Nutr Diet 35(1):94–101 PubMedCrossRef
51.
Lévy E, Palmer D, Frileux P, Parc R, Huguet C, Loygue J (1983) Inhibition of upper gastrointestinal secretions by reinfusion of succus entericus into the distal small bowel. A clinical study of 30 patients with peritonitis and temporary enterostomy. Ann Surg 198(5):596–600 PubMedPubMedCentralCrossRef
52.
Cooper JC, Williams NS, King RF, Barker MC (1986) Effects of a long-acting somatostatin analogue in patients with severe ileostomy diarrhoea. Br J Surg 73(2):128–131 PubMedCrossRef
53.
Jacobsen O, Ladefoged K, Stage JG, Jarnum S (1986) Effects of cimetidine on jejunostomy effluents in patients with severe short-bowel syndrome. Scand J Gastroenterol 21(7):824–828 PubMedCrossRef
54.
Nightingale JM, Walker ER, Burnham WR, Farthing MJ, Lennard-Jones JE (1989) Octreotide (a somatostatin analogue) improves the quality of life in some patients with a short intestine. Aliment Pharmacol Ther 3(4):367–373 PubMedCrossRef
55.
Nightingale J, Walker E, Farthing M, Lennard-Jones J (1991) Effect of omeprazole on intestinal output in the short bowel syndrome. Aliment Pharmacol Ther 5(4):405–412 PubMedCrossRef
56.
O’Keefe SJ, Peterson ME, Fleming CR (1994) Octreotide as an adjunct to home parenteral nutrition in the management of permanent end-jejunostomy syndrome. JPEN J Parenter Enteral Nutr 18(1):26–34 PubMedCrossRef
57.
Nehra V, Camilleri M, Burton D, Oenning L, Kelly DG (2001) An open trial of octreotide long-acting release in the management of short bowel syndrome. Am J Gastroenterol 96(5):1494–1498 PubMedCrossRef
58.
Ecker KW, Stallmach A, Löffler J, Greinwald R, Achenbach U (2005) Long-term treatment of high intestinal output syndrome with budesonide in patients with Crohn’s disease and ileostomy. Dis Colon Rectum 48(2):237–242 PubMedCrossRef
59.
Jeppesen PB (2005) Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients. Gut 54(9):1224–1231 PubMedPubMedCentralCrossRef
60.
Buchman A, Fryer J, Wallin A, Ahn C, Polensky S, Zaremba K (2006) Clonidine reduces diarrhea and sodium loss in patients with proximal jejunostomy: a controlled study. J Parenter Enter Nutr 30(6):487–491 CrossRef
61.
62.
Hvistendahl M, Brandt CF, Tribler S et al (2016) Effect of liraglutide treatment on jejunostomy output in patients with short bowel syndrome. J Parenter Enteral Nutr 42(1):112–121
63.
64.
Chia CLK, Tai YS, Tan K-Y (2017) A preliminary study of the use of oral rehydration salts in decreasing ileostomy output. Tech Coloproctol 21(7):587–588 PubMedCrossRef
65.
Picot D, Layec S, Seynhaeve E, Dussaulx L, Trivin F, Carsin-Mahe M (2020) Chyme reinfusion in intestinal failure related to temporary double enterostomies and enteroatmospheric fistulas. Nutrients 12(5):1376 PubMedPubMedCentralCrossRef
66.
Sobocki J, Zaczek Z, Jurczak P et al (2021) Restricted vs. unrestricted oral intake in high output end-jejunostomy patients referred to reconstructive surgery. Br J Nutr 125(10):1125–1131 PubMedCrossRef
67.
Zaczek Z, Dabrowska K, Omidi M, Panczyk M, Sobocki J (2022) Effect of thickening powder on gastrointestinal losses in patients with high-output end jejunostomy syndrome—preliminary results. In Vivo 36(2):884–889 PubMedPubMedCentralCrossRef
68.
Nightingale JM, Lennard-Jones JE, Walker ER, Farthing MJ (1990) Jejunal efflux in short bowel syndrome. Lancet 336(8718):765–768 PubMedCrossRef
69.
Hara Y, Miura T, Sakamoto Y, Morohashi H, Nagase H, Hakamada K (2020) Organ/space infection is a common cause of high output stoma and outlet obstruction in diverting ileostomy. BMC Surg 20(1):83 PubMedPubMedCentralCrossRef
70.
Teitelbaum EN, Vaziri K, Zettervall S, Amdur RL, Orkin BA (2013) Intraoperative small bowel length measurements and analysis of demographic predictors of increased length. Clin Anat 26(7):827–832 PubMedCrossRef
71.
Tacchino RM (2015) Bowel length: measurement, predictors, and impact on bariatric and metabolic surgery. Surg Obes Relat Dis 11(2):328–334 PubMedCrossRef
Metadata
Title
Clinical management of high-output stoma: a systematic literature review and meta-analysis
Authors
H. Lederhuber
L. H. Massey
V. E. Kantola
M. R. S. Siddiqui
A. E. Sayers
F. D. McDermott
I. R. Daniels
N. J. Smart
Publication date
18-06-2023
Publisher
Springer International Publishing
Published in
Techniques in Coloproctology / Issue 12/2023
Print ISSN: 1123-6337
Electronic ISSN: 1128-045X
DOI
https://doi.org/10.1007/s10151-023-02830-1

Other articles of this Issue 12/2023

Techniques in Coloproctology 12/2023 Go to the issue

Original Article

Low anterior resection syndrome and quality of life after intersphincteric resection for rectal cancer: a propensity score-matched study

Multimedia Article

Feasibility of transanal minimally invasive surgery for total pelvic exenteration for advanced primary and recurrent pelvic malignancies

Original Article

Interobserver agreement on landmark and flexure identification in colon capsule endoscopy

Correction

Correction to: Transanal irrigation in functional bowel disorders and LARS: short‑term results from an Italian national study

Original Article

Efficacy of laparoscopic surgery for loop colostomy: a propensity-score-matched analysis

Original Article

An updated evaluation of the implementation of the sigmoid take-off landmark 1 year after the official introduction in the Netherlands